BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15911088)

  • 1. Transcriptional control of fetal liver hematopoiesis: dominant negative effect of the overexpression of the LIM domain mutants of LMO2.
    Terano T; Zhong Y; Toyokuni S; Hiai H; Yamada Y
    Exp Hematol; 2005 Jun; 33(6):641-51. PubMed ID: 15911088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the key LMO2-binding determinants on Ldb1.
    Ryan DP; Sunde M; Kwan AH; Marianayagam NJ; Nancarrow AL; Vanden Hoven RN; Thompson LS; Baca M; Mackay JP; Visvader JE; Matthews JM
    J Mol Biol; 2006 May; 359(1):66-75. PubMed ID: 16616188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins.
    Wadman IA; Osada H; Grütz GG; Agulnick AD; Westphal H; Forster A; Rabbitts TH
    EMBO J; 1997 Jun; 16(11):3145-57. PubMed ID: 9214632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Lim-only protein LMO2 acts as a positive regulator of erythroid differentiation.
    Hansson A; Zetterblad J; van Duren C; Axelson H; Jönsson JI
    Biochem Biophys Res Commun; 2007 Dec; 364(3):675-81. PubMed ID: 17964543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
    El Omari K; Hoosdally SJ; Tuladhar K; Karia D; Vyas P; Patient R; Porcher C; Mancini EJ
    Blood; 2011 Feb; 117(7):2146-56. PubMed ID: 21076045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the lmo2 promoter during hematopoietic and vascular development in zebrafish.
    Zhu H; Traver D; Davidson AJ; Dibiase A; Thisse C; Thisse B; Nimer S; Zon LI
    Dev Biol; 2005 May; 281(2):256-69. PubMed ID: 15893977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
    Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
    Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidation of the role of LMO2 in human erythroid cells.
    Inoue A; Fujiwara T; Okitsu Y; Katsuoka Y; Fukuhara N; Onishi Y; Ishizawa K; Harigae H
    Exp Hematol; 2013 Dec; 41(12):1062-76.e1. PubMed ID: 24041784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the LMO4 gene encoding an interaction partner of the LIM-binding protein LDB1/NLI1: a candidate for displacement by LMO proteins in T cell acute leukaemia.
    Grutz G; Forster A; Rabbitts TH
    Oncogene; 1998 Nov; 17(21):2799-803. PubMed ID: 9840944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of chromosomal translocations in acute leukemias: the LMO2 paradigm in transcription and development.
    Rabbitts TH; Bucher K; Chung G; Grutz G; Warren A; Yamada Y
    Cancer Res; 1999 Apr; 59(7 Suppl):1794s-1798s. PubMed ID: 10197599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
    Gering M; Yamada Y; Rabbitts TH; Patient RK
    Development; 2003 Dec; 130(25):6187-99. PubMed ID: 14602685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation.
    Visvader JE; Mao X; Fujiwara Y; Hahm K; Orkin SH
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13707-12. PubMed ID: 9391090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1.
    Schlaeger TM; Schuh A; Flitter S; Fisher A; Mikkola H; Orkin SH; Vyas P; Porcher C
    Mol Cell Biol; 2004 Sep; 24(17):7491-502. PubMed ID: 15314159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target.
    Yamada Y; Pannell R; Forster A; Rabbitts TH
    Oncogene; 2002 Feb; 21(9):1309-15. PubMed ID: 11857074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ssdp1 regulates head morphogenesis of mouse embryos by activating the Lim1-Ldb1 complex.
    Nishioka N; Nagano S; Nakayama R; Kiyonari H; Ijiri T; Taniguchi K; Shawlot W; Hayashizaki Y; Westphal H; Behringer RR; Matsuda Y; Sakoda S; Kondoh H; Sasaki H
    Development; 2005 Jun; 132(11):2535-46. PubMed ID: 15857913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation.
    Xu Z; Huang S; Chang LS; Agulnick AD; Brandt SJ
    Mol Cell Biol; 2003 Nov; 23(21):7585-99. PubMed ID: 14560005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells.
    Grütz GG; Bucher K; Lavenir I; Larson T; Larson R; Rabbitts TH
    EMBO J; 1998 Aug; 17(16):4594-605. PubMed ID: 9707419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LIM-only protein Lmo2 forms a protein complex with erythroid transcription factor GATA-1.
    Osada H; Grutz GG; Axelson H; Forster A; Rabbitts TH
    Leukemia; 1997 Apr; 11 Suppl 3():307-12. PubMed ID: 9209374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis.
    Yamada Y; Warren AJ; Dobson C; Forster A; Pannell R; Rabbitts TH
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3890-5. PubMed ID: 9520463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of the LIM-domain-binding factor Ldb1 with LIM homeodomain proteins.
    Agulnick AD; Taira M; Breen JJ; Tanaka T; Dawid IB; Westphal H
    Nature; 1996 Nov; 384(6606):270-2. PubMed ID: 8918878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.